Trial Profile

Phase I Dose Finding/Phase II Placebo-Controlled Trial of Eltrombopag During Consolidation Therapy in Adults With Acute Myeloid Leukemia (AML) in Complete Remission

Status: Discontinued

Phase of Trial: Phase I/II

Latest Information Update: 28 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 Dec 2016 Results of phase I dose finding part of the trial, presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
06 Dec 2016 Status changed from active, no longer recruiting to discontinued due to recommendation of an independent data and monitoring committee, according to results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
11 Jan 2016 Planned End Date changed from 1 Dec 2016 to 1 Jun 2016 as reported by ClinicalTrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com